Luis A Ramon
Overview
Explore the profile of Luis A Ramon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin D, Perdiguero P, Morel E, Soleto I, Herranz-Jusdado J, Ramon L, et al.
Front Immunol
. 2021 Dec;
12:773888.
PMID: 34917087
CD38 is a multifunctional molecule that functions both as a transmembrane signaling receptor and as an ectoenzyme with important roles in cell adhesion, calcium regulation and signal transduction. Within the...
2.
Martos L, Bonanad S, Ramon L, Cid A, Bonet E, Corral J, et al.
Clin Chim Acta
. 2016 Jun;
459:101-104.
PMID: 27262823
Available assays for circulating levels of activated protein C (APC) are either time-consuming or difficult to use in a routine laboratory, or have a detection limit above normal levels. We...
3.
Braza-Boils A, Gilabert-Estelles J, Ramon L, Gilabert J, Mari-Alexandre J, Chirivella M, et al.
PLoS One
. 2013 Apr;
8(4):e62370.
PMID: 23620826
Unlabelled: Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent gynecological diseases. It has been suggested that modifications of both endometrial and peritoneal...
4.
Ramon L, Braza-Boils A, Gilabert J, Chirivella M, Espana F, Estelles A, et al.
Hum Reprod
. 2012 Aug;
27(10):3036-45.
PMID: 22904162
Study Question: Which is the role of microRNAs (miRNAs) related to several angiogenesis regulators such as VEGF-A (Vascular endothelial growth factor-A) and TSP-1 (Thrombospondin-1) in endometrial cancer? Summary Answer: A...
5.
Gilabert-Estelles J, Ramon L, Braza-Boils A, Gilabert J, Chirivella M, Espana F, et al.
Thromb Res
. 2011 Nov;
130(2):242-7.
PMID: 22055623
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism may have significance for PAI-1 expression. High levels of PAI-1 in endometrial cancer patients are associated with a poor prognosis. The objective of this...
6.
Ramon L, Braza-Boils A, Gilabert-Estelles J, Gilabert J, Espana F, Chirivella M, et al.
Hum Reprod
. 2011 Feb;
26(5):1082-90.
PMID: 21335415
Background: Endometriosis is a common, multifactorial disease in which angiogenesis may be involved in the growth of endometrium outside the uterus. microRNAs (miRNAs) are 21-22 nucleotide non-coding RNAs that regulate...
7.
Cosin R, Gilabert-Estelles J, Ramon L, Espana F, Gilabert J, Romeu A, et al.
Fertil Steril
. 2008 Oct;
92(4):1214-1220.
PMID: 18930211
Objective: To analyze three functional vascular endothelial growth factor (VEGF) polymorphisms (-460C/T, +405G/C, and 936C/T) in women with and without endometriosis and their correlation with VEGF expression in endometrial tissue...
8.
Zorio E, Gilabert-Estelles J, Espana F, Ramon L, Cosin R, Estelles A
Curr Med Chem
. 2008 May;
15(9):923-9.
PMID: 18473800
The fibrinolytic system includes a broad spectrum of proteolytic enzymes with physiological and pathophysiological functions in several processes, such as haemostatic balance, tissue remodeling, tumor invasion, angiogenesis and reproduction. The...
9.
Ramon L, Gilabert-Estelles J, Cosin R, Gilabert J, Espana F, Castello R, et al.
Thromb Res
. 2008 Apr;
122(6):854-60.
PMID: 18423526
Introduction: Endometriosis is a benign gynecologic disease with a high prevalence. It is a multifactorial and polygenic entity in which the fibrinolytic system may be implicated. The objective of this...
10.
Ricart J, Ramon L, Vaya A, Espana F, Santaolaria M, Todoli J, et al.
Br J Haematol
. 2008 Mar;
141(5):716-9.
PMID: 18341631
This study aimed to assess the fibrinolytic inhibitors and their association with thrombosis in Behçet disease. Thrombin activatable fibrinolysis inhibitor (TAFI) (P < 0.001) and plasminogen activator inhibitor-1 (PAI-1) levels...